Determining individual preferences for gynecomastia avoidance among men with prostate cancer: A qualitative study. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium.
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results